Author

John Lynch 1

1 Janssen Research & Development, LLC,Spring House,United States

AGREEMENT BETWEEN LOCALLY AND CENTRALLY REVIEWED MAYO ENDOSCOPIC SUBSCORES IN THE UNIFI STUDY OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS: CORROBORATION WITH FECAL CALPROTECTIN AND HISTOLOGY

Walter Reinisch, Colleen W. Marano, Allison Simi, John Lynch, Lenore Noonan, Hongyan Zhang, Bruce E. Sands, Daniel S. Mishkin

CORTICOSTEROID USE AND THE ASSOCIATED IMPACT ON PATIENTS WITH CROHN'S DISEASE (CD) AND ULCERATIVE COLITIS (UC) IN THE US, FRANCE, GERMANY, ITALY, SPAIN, AND UK (EU5)

Mirko Sikirica, John Lynch, Ben Hoskin, Jim Kershaw, Rosie Wild, Rina Lukanova

EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE THROUGH 5 YEARS: FINAL RESULTS FROM THE IM-UNITI LONG-TERM EXTENSION

William Sandborn, Paul Rutgeerts, John Lynch, Rory Rebuck, Yuhua Wang, Bin Zou, Christopher Gasink, Omoniyi J. Adedokun, Bruce E. Sands, Stephen B Hanauer, Stephan Targan, Subrata Ghosh, Willem de Villiers, Jean-Frederic Colombel, Brian G. Feagan

HUMANISTIC BURDEN AND IMPACT OF THE DISEASE IN MODERATE TO SEVERE PATIENTS WITH CROHN'S DISEASE (CD) AND ULCERATIVE COLITIS (UC): FINDINGS FROM A CROSS SECTIONAL STUDY IN THE US AND FRANCE, GERMANY, ITALY, SPAIN, UK (EU5)

Mirko Sikirica, John Lynch, Ben Hoskin, Jim Kershaw, Rosie Wild, Rina Lukanova

MANAGEMENT AND UNMET NEED AMONGST MILD AND MODERATE/ SEVERE CD AND UC PATIENTS: FINDINGS FROM A CROSS SECTIONAL STUDY IN THE US AND FRANCE, GERMANY, ITALY, SPAIN, UK (EU5)

Mirko Sikirica, John Lynch, Ben Hoskin, Jim Kershaw, Rosie Wild, Rina Lukanova

SAFETY OF USTEKINUMAB IN OLDER IBD PATIENTS (≥60 YEARS): POOLED SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 2 YEARS IN UC AND ALL APPROVED INDICATIONS

Subrata Ghosh, Elyssa Ott, Christopher Gasink, Ye Miao, Colleen W. Marano, John Lynch, Maria T. Abreu, Aline Charabaty

Item 1 - 6 / 6
1